Frozen section diagnosis of metastatic prostate adenocarcinoma in pelvic lymphadenectomy compared with nomogram prediction of metastasis

Urology

Volumn 59, Issue 5, 2002, Pages 721-725

  Beissner, R S ^a   Stricker, J B ^a   Speights, V O ^a   Coffield, K S ^a   Spiekerman, A M ^a   Riggs, M ^a  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; FROZEN SECTION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PELVIS LYMPHADENECTOMY; PREDICTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATECTOMY;

ADENOCARCINOMA; FROZEN SECTIONS; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; PELVIS; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0036253389     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01531-5     Document Type: Article

References (19)

1. Cancer statistics, 1998
2. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening
3. Management of cancer of the prostate
4. Competing risk analysis of men aged 55-74 years at diagnosis managed conservatively for clinically localized prostate cancer
5. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
6. The Prostate Cancer Intervention Versus Observation Trial: A randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer
7. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer
8. Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer
9. The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer
10. Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer
11. The role of digital rectal examination, biopsy Gleason sum, and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer
12. Open pelvic lymph node dissection for prostate cancer: A reassessment
13. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathologic stage of localized prostate cancer: A multi-institutional update
14. Validation of Partin tables for predicting pathologic stage of clinically localized prostrate cancer
15. Complete radical prostatectomy and positive lymph nodes (stages pT1 to 4, N1 to 3, M0, D1)
16. Sensitivity of frozen section examination of pelvic lymph nodes for metastatic prostate carcinoma
17. Prognostic factors in men with stage D1 prostate cancer: Identification of patients less likely to have prolonged survival after radical prostatectomy
18. No difference in biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients
19. When is pelvic node dissection necessary before radical prostatectomy? A decision analysis